Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Possible approaches to develop vaccines against hepatitis A.

E D'Hondt1

  • 1SmithKline Beecham Biologicals, Rixensart, Belgium.

Vaccine
|January 1, 1992
PubMed
Summary

Developing hepatitis A virus (HAV) vaccines has advanced through cell culture replication, leading to live attenuated and inactivated candidates. Research explores viral capsid protein configurations for optimal immunogenicity and protection against HAV infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report.

Acta gastro-enterologica Belgica·2023
Same author

The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.

Lung cancer (Amsterdam, Netherlands)·2021
Same author

Cell disruption for microalgae biorefineries.

Biotechnology advances·2015
Same author

A longitudinal analysis of gross motor coordination in overweight and obese children versus normal-weight peers.

International journal of obesity (2005)·2012
Same author

Renewable resources as a key to green chemistry.

Communications in agricultural and applied biological sciences·2010
Same author

Fos induction in the Japanese quail brain after expression of appetitive and consummatory aspects of male sexual behavior.

Brain research bulletin·2000

Area of Science:

  • Virology
  • Vaccinology
  • Immunology

Background:

  • Hepatitis A virus (HAV) replication in cell culture enabled vaccine development.
  • Serial passages in cell culture led to attenuated HAV vaccine candidates.
  • Improved viral antigen yield spurred development of inactivated HAV vaccines.

Purpose of the Study:

  • To review the development of hepatitis A virus (HAV) vaccine candidates.
  • To assess strategies for achieving immunogenic and protective HAV vaccines.
  • To evaluate different approaches including live attenuated, inactivated, and recombinant vaccines.

Main Methods:

  • Serial passages of HAV in cell culture for attenuation.
  • Development of formalin-inactivated vaccines using viral capsid antigens.
  • Expression of viral proteins using recombinant systems (e.g., vaccinia, baculovirus) and synthetic peptides.

Main Results:

  • Live attenuated HAV vaccine candidates showed efficacy in non-human primates and volunteers.
  • Inactivated HAV vaccines rely on the correct configuration of capsid proteins for immunogenicity.
  • Recombinant approaches using vaccinia virus showed protection, but with drawbacks; chimeric viruses were not immunogenic; empty virus particles show promise.

Conclusions:

  • HAV vaccine development has progressed significantly through cell culture and antigen expression technologies.
  • Preserving the correct configuration of viral capsid proteins is crucial for vaccine efficacy.
  • Emerging strategies like empty virus particles offer potential for future HAV vaccine development.

Related Experiment Videos